Concurrent Chemoradiation With or Without Durvalumab in Elderly Patients With Unresectable Stage III NSCLC: Safety and EfficacySally C. M. Lau, Adrian G. Sacher, Miguel García-Pardo et al.|JTO Clinical and Research Reports|2021Cited by 11
The Evolving Landscape of Antibody–Drug Conjugates for Urothelial CarcinomaMelissa L. Abel, Alexandra Drakaki, Aaron Burkenroad et al.|Clinical Genitourinary Cancer|2020Cited by 10